Functional Anorectal Pain & Coccygodynia

Supersedes and substantially expands the brief "Anorectal pain" section previously carried on Fecal Incontinence (sourced from ASCRS Ch03 - Anorectal Physiology, which explicitly deferred detailed diagnostic/management content to a later chapter — this page is that later content). Framed by the source within a broader chronic pelvic pain umbrella that also includes IBS-associated pelvic pain (see Irritable Bowel Syndrome (IBS)) and Pudendal Neuralgia, which is substantial enough to hold its own dedicated page.

Chronic pelvic pain overview

Chronic pelvic pain: lower abdominal pain lasting ≥6 months, unrelated to pregnancy, affecting up to 11% of the population, driven by a mix of physiologic and psychological factors. IBS symptoms are reported by up to 40% of women with chronic pelvic pain, and the two entities show similar symptom burden, psychosocial factors, and healthcare utilization. In a study of 987 women attending a pelvic pain clinic, muscular back pain, age >40, depression, 6–8 pain sites, higher symptom-distress scores, and a history of adult physical abuse were all associated with an IBS diagnosis among chronic pelvic pain patients. Treatment mirrors IBS-associated abdominal pain: neuromodulator selection by bowel habit (TCAs for diarrhea-predominant symptoms, SSRIs/SNRIs favored for constipation-predominant/mixed symptoms — see Irritable Bowel Syndrome (IBS)'s neuromodulation section for the full ladder). Pelvic floor dyssynergia (straining, incomplete emptying) is also prevalent in IBS patients and likely contributes to chronic pelvic pain, though these same symptoms can occur in chronic constipation without any anorectal-physiology abnormality — anorectal manometry is performed whenever dyssynergia is suspected (over 50% of a cohort of female non-IBS-D patients had anal pain correlating with abnormal anorectal physiology: absent relaxation/paradoxical contraction on strain in 91%, inadequate straining rectal pressure in 53%, prolonged balloon expulsion in 47%). Biofeedback therapy is the suggested treatment for IBS patients with demonstrated pelvic floor dyssynergia, alongside neuromodulators.

Functional anorectal pain — Rome IV subtypes

The Rome IV criteria describe three subtypes, distinguished primarily by pain duration and the presence/absence of anorectal tenderness on exam. All three require symptom fulfillment for the last 3 months with onset ≥6 months before diagnosis.

Imaging/anorectal physiology testing adds little to diagnosis beyond excluding other structural causes of anorectal pain.

Levator ani syndrome

Hypothesized mechanisms: pelvic floor muscle spasm with elevated anal resting pressure, or inflammation of the arcus tendon of the levator ani at its pubic ramus insertion. Onset associated with pelvic injury, childbirth, prior pelvic/spinal surgery, psychological stress, anxiety, depression. Pain typically worse sitting than lying/standing.

Treatment ladder:

• Digital massage of the puborectalis sling — the oldest described treatment; combined with hot sitz baths and oral diazepam, relieved symptoms in up to 68% of patients in early case series. Still typically tried before more invasive therapy.
• Biofeedback — a 157-patient RCT comparing biofeedback, electrogalvanic stimulation (EGS), and digital massage found biofeedback superior for pain relief and for restoring appropriate anal canal relaxation with straining (94% success) and defecation of a water-filled balloon (97% success). A separate retrospective cohort likewise found biofeedback outperformed TCAs, Botox injections, and sacral nerve stimulation, with the greatest benefit in patients whose predominant complaint was defecatory difficulty (65% improved vs. 35% without defecatory difficulty).
• Local steroid injection (triamcinolone/lidocaine into the point of maximal arcus tendon tenderness) showed better short-term results than EGS in one prospective comparison, though no difference at 12 months.
• Botulinum toxin results have been less promising for levator ani syndrome specifically: a 12-patient randomized, placebo-controlled, EMG-guided crossover trial (100 units at 90-day intervals) showed no change in pain frequency/intensity/duration vs. baseline; Botox combined with biofeedback performed somewhat better than Botox alone.

Proctalgia fugax

Most widely proposed mechanism: abnormal smooth-muscle contraction of the anal sphincter complex — proctalgia fugax is associated with a higher mean internal anal sphincter thickness/resting pressure than levator ani syndrome ("chronic proctalgia"). A familial form exists, associated with internal anal sphincter hypertrophy and comorbid constipation; in these patients, internal anal sphincter strip myomectomy improves the constipation but is less effective for the pain itself. Pudendal neuralgia is a separately reported cause: in a 68-patient proctalgia fugax cohort, 55 had tenderness along the pudendal nerve, and pudendal nerve block completely relieved symptoms in 65% and partially in 25% — see Pudendal Neuralgia.

Attacks are often precipitated by stress/anxiety. Acute measures: changing position, reassurance, warm baths, sublingual nifedipine or topical nitroglycerin, passing flatus, or an enema-assisted bowel movement. A randomized double-blind crossover trial found inhaled albuterol shortened time to pain relief (14 → 5 minutes), though its mechanism is unclear since it has no measurable effect on anal resting tone, sphincter relaxation, or rectal compliance when patients are asymptomatic. For persistent cases: biofeedback, local anesthetic blocks, or Botox (a 5-patient case series showed symptom resolution up to 2 years with 25 units, with elevated resting anal pressure normalizing after treatment) — internal anal sphincterotomy has also been described when conservative measures fail.

Coccygodynia

Pain/discomfort at or around the coccyx (including sacrum, anorectum, perineum), usually aggravated by prolonged sitting on hard surfaces; chronic if lasting >2 months. Two principal subtypes: trauma-related, and idiopathic (attributed to pelvic floor spasm, coccygeal bursa inflammation, degenerative joint disease, or sacrococcygeal joint hyper-/hypomobility). Obesity and female sex are predisposing factors via pelvic rotation and a more posterior, injury-prone coccyx position.

Diagnosis: reproduction of pain by external pressure/manipulation of the coccyx or during digital transrectal palpation. Pain worse leaning back while sitting, or transitioning sit-to-stand; improves with pressure relief on standing/walking. Most patients don't need imaging; when obtained, lateral sacral radiographs and dynamic sitting-vs-standing X-rays classify coccyx shape/inclination and bony pathology, while MRI excludes degenerative spine disease, tumor, or metastatic bone disease.

Treatment: 90% of patients improve with nonoperative care — rest, donut/wedge cushions, NSAIDs, heat/ice. Coccyx manipulation via the rectum can also help (a 102-patient RCT of coccygeal intrarectal manipulation vs. external magnetic field physiotherapy found manipulation more likely to reduce pain at 1 month — 36% vs. 20% — though neither arm showed a large effect). Ganglion impar blockade (fluoroscopy/CT-guided, with corticosteroid added to local anesthetic) is another option — a >70-patient double-blind RCT found local anesthetic plus corticosteroid reduced pain and depression at 1 and 3 months compared to local anesthetic alone. For nonoperative treatment failures, coccygectomy provides good/excellent relief in up to 85% of cases; a 109-patient retrospective cohort (average 4-year follow-up) found surgically treated patients had significantly less pain and better health status than nonsurgical patients, though wound infection (up to a quarter of patients) is the most common complication.

Related pages

• Irritable Bowel Syndrome (IBS) — the abdominal-pain/bowel-habit counterpart; shares the chronic-pelvic-pain framing and much of the neuromodulator treatment logic.
• Pudendal Neuralgia — a distinct entrapment neuropathy that overlaps mechanistically with proctalgia fugax and is diagnosed/treated on its own page given the depth of its content.
• Fecal Incontinence — anorectal pain is one of several pelvic-floor disorders that co-occur with urogynecologic conditions per that page's "Urogynecological considerations" section.
• Constipation — dyssynergic defecation/anismus overlaps with the pelvic floor dyssynergia discussed above under chronic pelvic pain.

Open items / gaps

• All content is textbook-level/secondary. Two individual studies flagged in Research Priorities.md as independent-verification candidates: the Chiarioni et al. 2010 biofeedback trial for levator ani syndrome and the Kleimeyer et al. 2017 coccygectomy-vs-nonoperative cohort.
• No trial directly compares the treatment ladders for levator ani syndrome vs. unspecified functional anorectal pain — nearly all cited evidence is levator-ani-syndrome-specific, leaving unspecified functional anorectal pain's own management largely inferred by analogy.
• The proctalgia fugax-pudendal neuralgia link (68-patient tenderness/block-response cohort) is a single study; the broader pudendal neuralgia literature (see Pudendal Neuralgia) is far more developed than this specific cross-link.